SARS-CoV-2 Nsp2 reprograms host immunity to drive pathogenic inflammation
Émile Lacasse, Isabelle Dubuc, Joannie Leclerc, Annie Gravel, Leslie Gudimard, Charles Joly-Beauparlant, Marion Faure, Patrick Fortin, Marie‐Renée Blanchet, Arnaud Droit, Louis Flamand
This study shows that SARS-CoV-2 Nsp2 drives immunopathology by reprogramming host immune responses, leading to more severe inflammation compared to its deletion mutant.
bioRxiv · May 7, 2026 · PreprintMicrobiology